Variables | Refractory angina symptoms | P value | Major adverse cardiac events | P value | |||
---|---|---|---|---|---|---|---|
Yes | No | Yes | No | ||||
Gender | Male | 4 (14.81%) | 23 (85.19%) | > 0.9999 | 0 (0%) | 27 (100%) | 0.1228 |
Female | 2 (14.28%) | 12 (85.71%) | 2 (14.28%) | 12 (85.71%) | |||
BMI | Normal | 1 (7.69%) | 12 (92.31%) | 0.19134 | 0 (0%) | 13 (100%) | 0.1317 |
Overweight | 1 (7.14%) | 13 (92.86%) | 0 (0%) | 14 (100%) | |||
Obese | 4 (28.57%) | 10 (71.42%) | 2 (14.28%) | 12 (85.72%) | |||
Hypertension | Yes | 4 (12.90%) | 27 (87.10%) | 0.6221 | 1 (4.76%) | 20 (95.24%) | > 0.9999 |
No | 2 (10%) | 18 (90%) | 1 (5%) | 19 (95%) | |||
Diabetes | Yes | 3 (27.27%) | 8 (72.73%) | 0.3162 | 1 (9.1%) | 10 (90.9%) | 0.4695 |
No | 3 (10%) | 27 (90%) | 1 (3.33%) | 29 (96.77%) | |||
Proton Pump Inhibitor Use | Yes | 4 (18.18%) | 18 (81.82%) | 0.6681 | 0 (0%) | 22 (100%) | 0.2085 |
No | 2 (10.52%) | 17 (89.47%) | 2 (10.53%) | 17 (89.47%) | |||
Calcium Chanel Blockers Use | Yes | 3 (30%) | 7 (70%) | 0.1435 | 0 (0%) | 10 (100%) | > 0.9999 |
No | 3 (9.67%) | 28 (90.33%) | 2 (6.45%) | 29 (93.55%) |